OVID vs PAYX · rev $733.0K vs P/E 22, rev $6.51B
Ovid Therapeutics Inc (OVID) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. Revenue was up 16.9% from 2025-05-31 to 2026-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
OVID currently screens at market cap $23.5M. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the OVID and PAYX stock pages for the full models.
Not investment advice.